Crossmark

Corticosteroid treatment for post-COVID-19 persistent interstitial lung disease: a randomized clinical trial

Crossref DOI link: https://doi.org/10.1016/j.bjid.2026.105892

Published Print: 2026-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Garcia, Rosângela Villela

Koenigkam-Santos, Marcel https://orcid.org/0000-0002-7160-4691
de Azevedo, Lucas Botelho https://orcid.org/0000-0001-7683-9978
Wada, Danilo Tadao https://orcid.org/0000-0002-6433-4849
Gastaldi, Ada Clarice https://orcid.org/0000-0001-9845-3611
Vianna, Elcio Oliveira https://orcid.org/0000-0003-1902-6326
Funding

Funding for this research was provided by:

FAEPA

State of Sao Paulo Research Foundation
License Information

Text and Data Mining valid from 2026-07-01

Text and Data Mining valid from 2026-07-01

Version of Record valid from 2026-06-25
More Information

This article is maintained by: Elsevier

Article Title: Corticosteroid treatment for post-COVID-19 persistent interstitial lung disease: a randomized clinical trial

Journal Title: The Brazilian Journal of Infectious Diseases

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.bjid.2026.105892

Content Type: article

Copyright: © 2026 Sociedade Brasileira de Infectologia. Published by Elsevier España, S.L.U.